Wed, November 6, 2019
Tue, November 5, 2019
Mon, November 4, 2019

Raghuram Selvaraju Maintained (SPRO) at Strong Buy with Increased Target to $35 on, Nov 5th, 2019

Raghuram Selvaraju of HC Wainwright & Co., Maintained "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $28 to $35 on, Nov 5th, 2019.

Raghuram, nor any peers, have made any analyst calls on SPRO in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30